Current status of clinical research in Covid-19 vaccines: A registry based audit
Keywords:
covid 19, vaccine, ctri, ctgov.inAbstract
The COVID-19 or Coronavirus has impacted the world in an unprecedented way. More than 200 countries have been affected because of this novel corona virus. There is a surge for identifying vaccine or repurposing existing drugs for this virus. The rapid spread has globally become a serious issue.The objective of the study was to provide a comprehensive overview on clinical trials that are being conducted in India and globally on vaccines for COVID-19. This is an observational study.All the clinical studies conducted in the field of vaccines registered on the ClinicalTrials.gov website and Clinical Trial Registry of India (CTRI) up to March 2021 were reviewed and analysed. The variables such as types of trials, study design, status of study whether ongoing or completed, type of intervention tested, sample size of trials,phases of trials were recorded. The data were analysed using descriptive statistics using SPSS 16.0.Out of all the studies registered, 263 were related to vaccine clinical trials among which 201 were interventional and 62 were observational. Out of 201 interventional studies,75.62% were randomised trials.Out of 62 observational studies,53.22% were cohort studies,20.96% were case control studies, 9.67% were cross sectional studies. Pure biologicals constituted 56.65% of the total interventions. Majority of the trials(23.88%) were in phase 1 and phase 3 respectively.3.8% trials have been completed, 44.48% trials are open for recruitment.2 trials have been suspended and withdrawn and 1 trial has been terminated.This study is helpful for researchers, policy makers, and general public for understanding COVID-19 clinical trials eco-system.It will also be useful for global scientific community to know what clinical trials are being conducted on COVID-19 vaccines and potential source of information for international collaborations.
Downloads
References
Weston S, Frieman MB. COVID-19: knowns, unknowns, and questions. mSphere. 2020;5(2): e00203–20.
Hiscott J, Alexandridi M, Muscolini M, Tassone E, Palermo E, Soultsioti M, et al. The global impact of the coronavirus pandemic.Cytokine Growth Factor Review 2020; 53: 1–9.
Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Research. 2020;288: 198114.
Strizova Z, Bartunkova J, Smrz D. Can wearing face masks in public affect transmission route and viral load in COVID-19? Central European Journal of Public Health. 2020; 28(2): 161–2.
Charan J, Kaur R, Bhardwaj P, Kanchan T, Mitra P, Yadav D, Sharma P, Misra S. Snapshot of COVID-19 related clinical trials in India. Indian Journal of Clinical Biochemistry. 2020 Oct;35(4):418-22.
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology. 2020;38(1): 1–9.
https://cdsco.gov.in/opencms/opencms/en/Home/ Accessed on 15th April 2021
https://www.theguardian.com/world/2021/jan/20/indian-hesitancy-sets-back-worlds-biggest-covid-vaccination-drive Accessed on 30th March 2021
https://www.hindustantimes.com/india-news/indias-inoculation-drive-now-second-largest-in-world-101615745738512-amp.html accessed on 30th march 2021
Selvarajan S, George M, Kumar SS, Dkhar SA. Clinical trials in India: Where do we stand globally?. Perspectives in Clinical Research. 2013;4(3):160-164. doi:10.4103/2229-3485.115373
MoHFW. (2020, July 31). Ministry of Health & Family Welfare, Government of India, Covid-19 India dashboard. Retrieved from https://www.mohfw.gov.in/
Mehta, H. B., Ehrhardt, S., Moore, T. J., Segal, J. B., & Alexander, G. C. (2020). Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis. British Medical Journal Open, 10(6), e039978.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 International Journal of Pharmacological Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article